Proportion of patients with increased aminotransferases levels at any time-point throughout the follow-up.

Luis F. López-Cortés (189634)
Pompeyo Viciana (189676)
José A. Girón-González (565446)
Alberto Romero-Palacios (565447)
Manuel Márquez-Solero (5659135)
Maria A. Martinez-Perez (565448)
Miguel A. López-Ruz (565449)
Javier de la Torre-Lima (565450)
Francisco Téllez-Pérez (565451)
Marcial Delgado-Fernández (565452)
Milagros Garcia-Lázaro (565453)
Fernando Lozano (565454)
Mohamed O. Mohamed-Balghata (565455)

Open link

Publication date

May 2014

DOI

10.1371/journal.pone.0097262.g002

Abstract

Proportion of patients with increased aminotransferases levels at any time-point throughout the follow-up.</p

Extracted data

We use cookies to provide a better user experience.

Data Protection

Proportion of patients with increased aminotransferases levels at any time-point throughout the follow-up.

Luis F. López-Cortés (189634)
Pompeyo Viciana (189676)
José A. Girón-González (565446)
Alberto Romero-Palacios (565447)
Manuel Márquez-Solero (5659135)
Maria A. Martinez-Perez (565448)
Miguel A. López-Ruz (565449)
Javier de la Torre-Lima (565450)
Francisco Téllez-Pérez (565451)
Marcial Delgado-Fernández (565452)
Milagros Garcia-Lázaro (565453)
Fernando Lozano (565454)
Mohamed O. Mohamed-Balghata (565455)

Open link

Publication date

May 2014

DOI

10.1371/journal.pone.0097262.g002

Abstract

Proportion of patients with increased aminotransferases levels at any time-point throughout the follow-up.</p

Extracted data

Maria Antonella Burza (157499)
Stefano Romeo (157548)
Anna Kotronen (181254)
Per-Arne Svensson (157540)
Kajsa Sjöholm (351309)
Jarl S. Torgerson (394561)
Anna-Karin Lindroos (394562)
Lars Sjöström (111105)
Lena M. S. Carlsson (111109)
Markku Peltonen (157537)

March 2013

HT group was defined if one or both transaminase levels were above the following cut-offs: AST ≥3...

Frequencies of amino acid substitutions with the highest variability during sequential treatment in each of the five treatment samples.

Francisco Rodriguez-Frías (161058)
David Tabernero (161063)
Josep Quer (161069)
Juan I. Esteban (161076)
Israel Ortega (161084)
Esteban Domingo (86438)
Maria Cubero (161092)
Sílvia Camós (161097)
Carles Ferrer-Costa (10293)
Alex Sánchez (161103)
Rosendo Jardí (161112)
Melanie Schaper (161118)
Maria Homs (161121)
Damir Garcia-Cehic (161129)
Jaume Guardia (161135)
Rafael Esteban (161141)
Maria Buti (161144)

May 2012

Frequencies of amino acid substitutions with the highest variability during sequential treatment ...

Percentage of patients who seroconverted or seroreverted at follow-up in nested longitudinal analysis, by ELISA type.

Paula B. Blomquist (6061163)
Stephanie J. Mighelsen (6091364)
Gillian Wills (354882)
Eleanor McClure (6091367)
Anthony E. Ades (6091370)
Daphne Kounali (622186)
J. Kevin Dunbar (6091373)
Myra O. McClure (193123)
Kate Soldan (408907)
Sarah C. Woodhall (448596)
Patrick Horner (6091376)

December 2018

Percentage of patients who seroconverted or seroreverted at follow-up in nested longitudinal analysi...

Proportion of the patients based on severity of pathological findings according to circulating TNFRs levels.

Su Mi Lee (451172)
SeungHee Yang (609895)
Ran-hui Cha (230898)
Myounghee Kim (277262)
Jung Nam An (396935)
Jin Ho Paik (165466)
Dong Ki Kim (165482)
Shin-Wook Kang (277265)
Chun Soo Lim (165488)
Yon Su Kim (165494)
Jung Pyo Lee (165431)

August 2014

(A) Correlation between the pathological findings and the circulating TNFR1 tertiles. (B) Correla...

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on varying population INHR-TB prevalence.

Kamila Romanowski (6260870)
Jonathon R. Campbell (4543495)
Olivia Oxlade (66115)
Federica Fregonese (442412)
Dick Menzies (66118)
James C. Johnston (370579)

January 2019

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on ...

Stacked bar chart of the distributions (%) of aspartate (AST) and alanine (ALT) aminotransferase levels at the latest hospital admission among the cases of natural death and the remaining non-cases of the original cohort, respectively.

Chian-Jue Kuo (335840)
Shang-Ying Tsai (335841)
Ya-Tang Liao (335843)
Yeates Conwell (335845)
Wen-Chung Lee (73587)
Ming-Chyi Huang (335846)
Shih-Ku Lin (335847)
Chiao-Chicy Chen (335848)
Wei J. Chen (213644)

February 2013

Stacked bar chart of the distributions (%) of aspartate (AST) and alanine (ALT) aminotransferase ...

Number of patients with abnormal values of serum levels of AST, ALT and total bilirubin at T0, T1 and T2.

Francesco Somma (760279)
Roberto D’Angelo (760280)
Nicola Serra (760281)
Gianluca Gatta (760282)
Roberto Grassi (760283)
Francesco Fiore (760284)

June 2015

Note. Data in parentheses are percentages.T0 = baseline, one day before ...

Proportion of subjects with 4-fold increase from baseline in anti-EBA175 antibody response.

Kwadwo A. Koram (172174)
Bright Adu (133241)
Josephine Ocran (324669)
Yaa S. Karikari (3127095)
Susan Adu-Amankwah (3127104)
Michael Ntiri (3127098)
Benjamin Abuaku (3127101)
Daniel Dodoo (40242)
Ben Gyan (134411)
Karl C. Kronmann (317416)
Francis Nkrumah (78754)

September 2016

Proportion of subjects with 4-fold increase from baseline in anti-EBA175 antibody response.</p

Proportion of patients with acquired MDR-TB after initial attempt at diagnosis and treatment, based on varying population INHR-TB prevalence.

Kamila Romanowski (6260870)
Jonathon R. Campbell (4543495)
Olivia Oxlade (66115)
Federica Fregonese (442412)
Dick Menzies (66118)
James C. Johnston (370579)

January 2019

Proportion of patients with acquired MDR-TB after initial attempt at diagnosis and treatment, based ...

Number and proportion of patients acquiring P. aeruginosa and its resistance phenotypes in the different periods.

Nazaret Cobos-Trigueros (3091056)
Mar Solé (3178701)
Pedro Castro (3178710)
Jorge Luis Torres (3178698)
Mariano Rinaudo (3178716)
Elisa De Lazzari (672963)
Laura Morata (3091068)
Cristina Hernández (109452)
Sara Fernández (3178704)
Alex Soriano (3091062)
José María Nicolás (3178713)
Josep Mensa (3178707)
Jordi Vila (200623)
José Antonio Martínez (126168)

March 2016

Number and proportion of patients acquiring P. aeruginosa and its resistance phenot...

Proportion of participants reporting symptoms at enrolment and during each week of follow up.

Anna P. Ralph (445608)
Enny Kenangalem (35528)
Govert Waramori (445609)
Gysje J. Pontororing (445610)
Sandjaja (445612)
Emiliana Tjitra (35536)
Graeme P. Maguire (445618)
Paul M. Kelly (336096)
Nicholas M. Anstey (35535)

November 2013

Proportion of participants reporting symptoms at enrolment and during each week of follow up.</p

Number of patients in Part B of study with episodes of high or low level viraemia.

Paul D. Griffiths (470964)
Emily Rothwell (3186069)
Mohammed Raza (3186084)
Stephanie Wilmore (3186072)
Tomas Doyle (3186096)
Mark Harber (3186078)
James O’Beirne (3186081)
Stephen Mackinnon (510464)
Gareth Jones (34552)
Douglas Thorburn (3186093)
Frank Mattes (3186087)
Gaia Nebbia (125377)
Sowsan Atabani (3186090)
Colette Smith (715430)
Anna Stanton (3186066)
Vincent C. Emery (3186075)

September 2016

Number of patients in Part B of study with episodes of high or low level viraemia.</p

Changes in the concentration of biochemical indicators among the participants during the follow-up period.

Łukasz Tota (6243731)
Anna Piotrowska (802338)
Tomasz Pałka (2806816)
Małgorzata Morawska (6243734)
Wioletta Mikuľáková (6243737)
Dariusz Mucha (1888993)
Magdalena Żmuda-Pałka (6243740)
Wanda Pilch (510885)

January 2019

Changes in the concentration of biochemical indicators among the participants during the follow-up p...

High transaminase (HT) incidence and remission in the surgery and the control groups at 2- and 10-year follow up.

Maria Antonella Burza (157499)
Stefano Romeo (157548)
Anna Kotronen (181254)
Per-Arne Svensson (157540)
Kajsa Sjöholm (351309)
Jarl S. Torgerson (394561)
Anna-Karin Lindroos (394562)
Lars Sjöström (111105)
Lena M. S. Carlsson (111109)
Markku Peltonen (157537)

March 2013

HT group was defined if one or both transaminase levels were above the following cut-offs: AST ≥3...

Frequencies of amino acid substitutions with the highest variability during sequential treatment in each of the five treatment samples.

Francisco Rodriguez-Frías (161058)
David Tabernero (161063)
Josep Quer (161069)
Juan I. Esteban (161076)
Israel Ortega (161084)
Esteban Domingo (86438)
Maria Cubero (161092)
Sílvia Camós (161097)
Carles Ferrer-Costa (10293)
Alex Sánchez (161103)
Rosendo Jardí (161112)
Melanie Schaper (161118)
Maria Homs (161121)
Damir Garcia-Cehic (161129)
Jaume Guardia (161135)
Rafael Esteban (161141)
Maria Buti (161144)

May 2012

Frequencies of amino acid substitutions with the highest variability during sequential treatment ...

Percentage of patients who seroconverted or seroreverted at follow-up in nested longitudinal analysis, by ELISA type.

Paula B. Blomquist (6061163)
Stephanie J. Mighelsen (6091364)
Gillian Wills (354882)
Eleanor McClure (6091367)
Anthony E. Ades (6091370)
Daphne Kounali (622186)
J. Kevin Dunbar (6091373)
Myra O. McClure (193123)
Kate Soldan (408907)
Sarah C. Woodhall (448596)
Patrick Horner (6091376)

December 2018

Percentage of patients who seroconverted or seroreverted at follow-up in nested longitudinal analysi...

Proportion of the patients based on severity of pathological findings according to circulating TNFRs levels.

Su Mi Lee (451172)
SeungHee Yang (609895)
Ran-hui Cha (230898)
Myounghee Kim (277262)
Jung Nam An (396935)
Jin Ho Paik (165466)
Dong Ki Kim (165482)
Shin-Wook Kang (277265)
Chun Soo Lim (165488)
Yon Su Kim (165494)
Jung Pyo Lee (165431)

August 2014

(A) Correlation between the pathological findings and the circulating TNFR1 tertiles. (B) Correla...

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on varying population INHR-TB prevalence.

Kamila Romanowski (6260870)
Jonathon R. Campbell (4543495)
Olivia Oxlade (66115)
Federica Fregonese (442412)
Dick Menzies (66118)
James C. Johnston (370579)

January 2019

Total proportion of patients with MDR-TB after initial attempt at diagnosis and treatment, based on ...

Chian-Jue Kuo (335840)
Shang-Ying Tsai (335841)
Ya-Tang Liao (335843)
Yeates Conwell (335845)
Wen-Chung Lee (73587)
Ming-Chyi Huang (335846)
Shih-Ku Lin (335847)
Chiao-Chicy Chen (335848)
Wei J. Chen (213644)

February 2013

Stacked bar chart of the distributions (%) of aspartate (AST) and alanine (ALT) aminotransferase ...

Number of patients with abnormal values of serum levels of AST, ALT and total bilirubin at T0, T1 and T2.

Francesco Somma (760279)
Roberto D’Angelo (760280)
Nicola Serra (760281)
Gianluca Gatta (760282)
Roberto Grassi (760283)
Francesco Fiore (760284)

June 2015

Note. Data in parentheses are percentages.T0 = baseline, one day before ...

Proportion of subjects with 4-fold increase from baseline in anti-EBA175 antibody response.

Kwadwo A. Koram (172174)
Bright Adu (133241)
Josephine Ocran (324669)
Yaa S. Karikari (3127095)
Susan Adu-Amankwah (3127104)
Michael Ntiri (3127098)
Benjamin Abuaku (3127101)
Daniel Dodoo (40242)
Ben Gyan (134411)
Karl C. Kronmann (317416)
Francis Nkrumah (78754)

September 2016

Proportion of subjects with 4-fold increase from baseline in anti-EBA175 antibody response.</p

Proportion of patients with acquired MDR-TB after initial attempt at diagnosis and treatment, based on varying population INHR-TB prevalence.

Kamila Romanowski (6260870)
Jonathon R. Campbell (4543495)
Olivia Oxlade (66115)
Federica Fregonese (442412)
Dick Menzies (66118)
James C. Johnston (370579)

January 2019

Proportion of patients with acquired MDR-TB after initial attempt at diagnosis and treatment, based ...

Number and proportion of patients acquiring P. aeruginosa and its resistance phenotypes in the different periods.

Nazaret Cobos-Trigueros (3091056)
Mar Solé (3178701)
Pedro Castro (3178710)
Jorge Luis Torres (3178698)
Mariano Rinaudo (3178716)
Elisa De Lazzari (672963)
Laura Morata (3091068)
Cristina Hernández (109452)
Sara Fernández (3178704)
Alex Soriano (3091062)
José María Nicolás (3178713)
Josep Mensa (3178707)
Jordi Vila (200623)
José Antonio Martínez (126168)

March 2016

Number and proportion of patients acquiring P. aeruginosa and its resistance phenot...

Proportion of participants reporting symptoms at enrolment and during each week of follow up.

Anna P. Ralph (445608)
Enny Kenangalem (35528)
Govert Waramori (445609)
Gysje J. Pontororing (445610)
Sandjaja (445612)
Emiliana Tjitra (35536)
Graeme P. Maguire (445618)
Paul M. Kelly (336096)
Nicholas M. Anstey (35535)

November 2013

Proportion of participants reporting symptoms at enrolment and during each week of follow up.</p

Number of patients in Part B of study with episodes of high or low level viraemia.

Paul D. Griffiths (470964)
Emily Rothwell (3186069)
Mohammed Raza (3186084)
Stephanie Wilmore (3186072)
Tomas Doyle (3186096)
Mark Harber (3186078)
James O’Beirne (3186081)
Stephen Mackinnon (510464)
Gareth Jones (34552)
Douglas Thorburn (3186093)
Frank Mattes (3186087)
Gaia Nebbia (125377)
Sowsan Atabani (3186090)
Colette Smith (715430)
Anna Stanton (3186066)
Vincent C. Emery (3186075)

September 2016

Number of patients in Part B of study with episodes of high or low level viraemia.</p

Changes in the concentration of biochemical indicators among the participants during the follow-up period.

Łukasz Tota (6243731)
Anna Piotrowska (802338)
Tomasz Pałka (2806816)
Małgorzata Morawska (6243734)
Wioletta Mikuľáková (6243737)
Dariusz Mucha (1888993)
Magdalena Żmuda-Pałka (6243740)
Wanda Pilch (510885)

January 2019

Changes in the concentration of biochemical indicators among the participants during the follow-up p...

High transaminase (HT) incidence and remission in the surgery and the control groups at 2- and 10-year follow up.

Maria Antonella Burza (157499)
Stefano Romeo (157548)
Anna Kotronen (181254)
Per-Arne Svensson (157540)
Kajsa Sjöholm (351309)
Jarl S. Torgerson (394561)
Anna-Karin Lindroos (394562)
Lars Sjöström (111105)
Lena M. S. Carlsson (111109)
Markku Peltonen (157537)

March 2013

HT group was defined if one or both transaminase levels were above the following cut-offs: AST ≥3...

Frequencies of amino acid substitutions with the highest variability during sequential treatment in each of the five treatment samples.

Francisco Rodriguez-Frías (161058)
David Tabernero (161063)
Josep Quer (161069)
Juan I. Esteban (161076)
Israel Ortega (161084)
Esteban Domingo (86438)
Maria Cubero (161092)
Sílvia Camós (161097)
Carles Ferrer-Costa (10293)
Alex Sánchez (161103)
Rosendo Jardí (161112)
Melanie Schaper (161118)
Maria Homs (161121)
Damir Garcia-Cehic (161129)
Jaume Guardia (161135)
Rafael Esteban (161141)
Maria Buti (161144)

May 2012

Frequencies of amino acid substitutions with the highest variability during sequential treatment ...

Proportion of patients with increased aminotransferases levels at any time-point throughout the follow-up.

Abstract

Extracted data

Proportion of patients with increased aminotransferases levels at any time-point throughout the follow-up.

Abstract

Extracted data

Related items

Related items